Writing Samples
I provide a variety of writing services. Jobs and formats include abstracts, blogs, CME, copywriting, drug fact sheets, executive summaries, journal articles, mobile apps, needs assessments, newsletters, patient education, peer-reviewed manuscripts, posters, researching, sales aids, sales training modules, slides and notes, tables and figures, video scripts, web content, and white papers.
The following samples are (or have been) freely available online or are offered as PDFs. Proprietary material is not listed because of confidentiality requirements. In each case, I was the sole writer or collaborating writer.
Abstracts • Blogs • CME • Journal articles • Mobile apps • Peer-reviewed manuscripts • Posters • Sales training modules • Slide decksAbstracts
American Academy of Dermatology. DermClips Newsletter. [bimonthly abstracts, 2008-2014] See PDF
Contemporary OB/GYN literature summaries. See PDF
Emergency Medical Abstracts and Primary Care Medical Abstracts. The Center for Medical Education. http://www.ccme.org. [monthly abstracts, 2014-2018]
Blogs
Cleveland Clinic. Consult QD. Lung cancer care path: efficient care, lower costs. June 1, 2015. https://consultqd.clevelandclinic.org/asco-2015-lung-cancer-care-path/ See online
Cleveland Clinic. Consult QD. Metabolite of abiraterone shows efficacy against castration-resistant prostate cancer. August 26, 2015. https://consultqd.clevelandclinic.org/metabolite-of-abiraterone-shows-efficacy-against-castration-resistant-prostate-cancer/ See online
CME
Familial hypercholesterolemia. [needs assessment; redacted and posted with permission] See PDF
OFF to ON: strategies to manage OFF episodes in patients with Parkinson’s disease. Released January 30, 2021. https://www.mycme.com/courses/off-to-on-strategies-to-manage-off-episodes-in-patients-with-parkinsons-disease-7561 See online
Journal articles
Cohen HP. Biosimilar development—approval of biosimilar medicines through totality of the evidence. Drug Development & Delivery. June 2019. See online
Lackland DT. The scope of the burden of atrial fibrillation. Federal Practitioner. 2010;27(Suppl 10):3-6. See PDF
Monoclonal antibodies and small-molecule drugs: what general neurologists need to know. Amgen Inc. and Novartis Pharmaceuticals Corporation. Neurology Reviews. 2020;28(4):S1-S4. See online
Ninger L. The role of lasers in noninvasive fat reduction and body contouring. Dermatology World. 2010;20(2 Suppl):10,14. See PDF
Ninger L. Special report. Update on first-line treatment of non-small cell lung cancer. New York, NY: McMahon Publishing Group; 2002. See PDF
Mobile apps
American Academy of Dermatology. Chronic urticaria mobile app. 2015.
Peer-reviewed manuscripts
Archer DF, Simon JA, Portman DJ, Goldstein SR, Goldstein I. Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. Expert Rev Endocrinol Metab. 2019;14(5):301-314. [see acknowledgment] See online
Chan EKH, Williams V, Romano C, et al. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial. J Patient Rep Outcomes. 2023;7(1):45. [see acknowledgment] See online
Cole BJ, Kaiser JT, Wagner KR, Gomoll AH. Safety of an allogeneic, human, umbilical cord blood-derived mesenchymal stem cells-4% hyaluronate composite for cartilage repair in the knee. Journal of Cartilage & Joint Preservation. Published online January 31, 2022. [see acknowledgment] See online
de Villiers TJ, Altomare C, Particco M, Gambacciani M. Effects of ospemifene on bone in postmenopausal women. Climacteric. 2019;22(5):442-447. [see acknowledgment] See online
Eldadah ZA, Al-Ahmad A, Bunch TJ, et al. Same-day discharge following catheter ablation and venous closure with VASCADE MVP: a postmarket registry. J Cardiovasc Electrophysiol. 2023;34(2):348-355. [see acknowledgment] See abstract
Flack JM, Buhnerkempe MG, Moore KT. Resistant hypertension: disease burden and emerging treatment options. Curr Hypertens Rep. 2024;26(5):183-199. [see acknowledgment] See online
Grupp SA, Corbacioglu S, Kang HJ, et al. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Lancet Haematol. 2023;10(5):e333-e345. [see acknowledgment] See abstract
Jacobson CA, Rosenthal AC, Arnason J, et al. A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndrome. Blood Adv. 2023;7(21):6790-6799. [see acknowledgment] See online
Kaminsky DA, Grosset DG, Kegler-Ebo DM, et al. Natural history of lung function over one year in patients with Parkinson's disease. Respir Med. 2021;182:106396. [see acknowledgment] See online
Liu JH, Bernick B, Mirkin S. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion. Expert Opin Drug Deliv. 2020;17(11):1573-1581. [see acknowledgment] See online
Morschhauser F, Le Gouill S, Feugier P, et al. Obinutuzumab combined with lenalidomide (GALEN) for relapsed or refractory follicular B-cell lymphoma: a phase 2 study by the Lymphoma Study Association. Lancet Haematol. 2019;6(8):e429-e437. [see acknowledgment] See online
Morschhauser F, Salles G, Le Gouill S, et al. An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma. Blood. 2018;132(14):1486-1494. [see acknowledgment] See online
Sands J, Subramanian J. Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting. Front Oncol. 2023;13:1161931. [see acknowledgment] See online
Simon JA, Pickar JH, Shadiack AM, et al. Physical characteristics and properties of estradiol softgel vaginal inserts. Menopause. 2020;27(2):150-155. [see acknowledgment] See online
Wang L, Yang W, Wang Y, et al. Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma. BMC Cancer. 2025;25(1):836. [see acknowledgment] See online
Posters
Pickar JH, Archer DF, Goldstein SR, Kagan R, Bernick B, Mirkin S. Uterine bleeding rates with hormone therapies in menopausal women with vasomotor symptoms. Poster presented at: 2019 Annual Meeting of the North American Menopause Society; September 25-28, 2019; Chicago, IL. [see acknowledgment] See online
Sammons SL, Meisel JL, Pluard TJ, et al. Patient-provider communication challenges about side effects from metastatic breast cancer (mBC) treatments. Poster presented at: San Antonio Breast Cancer Symposium; December 5-9, 2023; San Antonio, Texas. [see acknowledgment] See online
Sammons SL, Meisel JL, Shanahan K, et al. Minimization of treatment toxicity/side effects and their impact on quality of life in patients with ER+/HER2- metastatic breast cancer (mBC). Poster presented at: San Antonio Breast Cancer Symposium; December 5-9, 2023; San Antonio, Texas. [see acknowledgment] See online
Sales training modules
Projects on a variety of disease states and pharmaceuticals, involving use of templates (eg, RISE, Adapt/Crosstrainer), writing progress questions, PDF markup, annotating, and client/MLR revisions; projects are proprietary
Slide decks
Complications of antiretroviral therapy slide deck. See PDF
Introduction to Healthcare and Public Health in the US. Component 1, Unit 2: Delivering Healthcare. Oregon Health and Science University; 2012. See slide deck PDF and See audio transcript PDF